Breakthrough T1D Hosts 3D Bioprinting Workshop for Type 1 Diabetes
Breakthrough T1D is committed to developing cell replacement therapies that will one day offer cures for type 1 diabetes (T1D).…
Gather your T1D back to school resources
Summer’s winding down and it is time to go back to school. With type 1 diabetes (T1D), back to school…
Triple Therapy in T1D: Breakthrough T1D Researchers Launch a Clinical Trial
Since its discovery nearly 100 years ago, insulin has been the only effective treatment for type 1 diabetes (T1D). Improvements…
Summer Internship Experience at Breakthrough T1D
By Jordan Garrick Ever since I was first diagnosed with type 1 diabetes (T1D), Breakthrough T1D has supported me through…
FDA Breakthrough Therapy Designation for Teplizumab—Based on the First Study to Delay the Onset of T1D for 2+ Years
The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to teplizumab, an anti-CD3 monoclonal antibody, for the prevention…
FDA Approves Baqsimi: The First Low Blood Sugar Treatment WITHOUT an Injection
Type 1 diabetes (T1D) can bring the fear of developing low blood sugar, called hypoglycemia, which can arise if someone…
Breakthrough T1D Young Adult Conference Schedule of Events – Orlando, FL
The Breakthrough T1D Young Adult Conference will be held October 12-13, 2019 in Orlando, Florida. Saturday, October 12 10:00 am…
Children’s Congress Photo Gallery
“It is a life dream of mine to not have ‘what is my sugar’ as my waking thought, delve into…
Children’s Congress shaped perspectives of type 1 diabetes and the need to do more
Our Breakthrough T1D Children’s Congress Delegates have left Washington, DC. But they’ve made a lasting impression and paved a solid…
FDA Welcomes Teen Perspective During Children’s Congress
What would intimidate even the most seasoned speakers had little impact on the three teens who met with the Food…
